225 related articles for article (PubMed ID: 27427210)
1. Advances in assessing ingredient safety.
Dourson ML; York RG
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 2():S112-8. PubMed ID: 27427210
[TBL] [Abstract][Full Text] [Related]
2. The relevance of international assessments to GRAS determinations.
Kruger C
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 2():S119-23. PubMed ID: 27318100
[TBL] [Abstract][Full Text] [Related]
3. Overview of the ISRTP October 2014 workshop on GRAS determinations.
McColl DB; Janus ER
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 2():S95-8. PubMed ID: 27392697
[TBL] [Abstract][Full Text] [Related]
4. GRAS determination scientific procedures and possible alternatives.
Williams GM; Kobets T; Iatropoulos MJ; Duan JD; Brunnemann KD
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 2():S105-11. PubMed ID: 27328372
[TBL] [Abstract][Full Text] [Related]
5. Chemistry, manufacturing and exposure assessments to support generally recognized as safe (GRAS) determinations.
Barraj L; Murphy M; Tran N; Petersen B
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 2():S99-S104. PubMed ID: 27389281
[TBL] [Abstract][Full Text] [Related]
6. A hard look at FDA's review of GRAS notices.
Roberts A; Haighton LA
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 2():S124-8. PubMed ID: 27318099
[TBL] [Abstract][Full Text] [Related]
7. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
8. Rebooting the generally recognized as safe (GRAS) approach for food additive safety in the US.
Hartung T
ALTEX; 2018; 35(1):3-25. PubMed ID: 29374436
[TBL] [Abstract][Full Text] [Related]
9. Making regulatory decisions across the food ingredient spectrum.
Rulis AM
Drug Metab Rev; 1996; 28(1-2):197-208. PubMed ID: 8744596
[TBL] [Abstract][Full Text] [Related]
10. Background to the ADI/TDI/PTWI.
Herrman JL; Younes M
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S109-13. PubMed ID: 10597623
[TBL] [Abstract][Full Text] [Related]
11. Bioactive nutrients - Time for tolerable upper intake levels to address safety.
Yates AA; Erdman JW; Shao A; Dolan LC; Griffiths JC
Regul Toxicol Pharmacol; 2017 Mar; 84():94-101. PubMed ID: 28110066
[TBL] [Abstract][Full Text] [Related]
12. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
[TBL] [Abstract][Full Text] [Related]
13. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory?
Silverglade BA
Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324
[No Abstract] [Full Text] [Related]
14. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
Mattia A; Merker R
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S115-8; discussion S144-51. PubMed ID: 18181714
[TBL] [Abstract][Full Text] [Related]
15. Characterisation and toxicological assessment of Neutral Methacrylate Copolymer for GRAS evaluation.
Eisele J; Haynes G; Kreuzer K; Rosamilia T
Regul Toxicol Pharmacol; 2013 Dec; 67(3):392-408. PubMed ID: 24012708
[TBL] [Abstract][Full Text] [Related]
16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts.
Zu K; Pizzurro DM; Lewandowski TA; Goodman JE
Regul Toxicol Pharmacol; 2017 Oct; 89():83-94. PubMed ID: 28720346
[TBL] [Abstract][Full Text] [Related]
18. Does EU legislation allow the use of the Benchmark Dose (BMD) approach for risk assessment?
Brandon EF; Bulder AS; van Engelen JG; Mahieu CM; Mennes WC; Pronk ME; Rietveld AG; van de Ven BM; Ten Voorde SE; Wolterink G; Slob W; Zeilmaker MJ; Bessems JG
Regul Toxicol Pharmacol; 2013 Nov; 67(2):182-8. PubMed ID: 23871753
[TBL] [Abstract][Full Text] [Related]
19. Incidence and severity in relation to magnitude of intake above the ADI or TDI: use of critical effect data.
Renwick AG
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S79-86. PubMed ID: 10597618
[TBL] [Abstract][Full Text] [Related]
20. The safety and regulation of natural products used as foods and food ingredients.
Abdel-Rahman A; Anyangwe N; Carlacci L; Casper S; Danam RP; Enongene E; Erives G; Fabricant D; Gudi R; Hilmas CJ; Hines F; Howard P; Levy D; Lin Y; Moore RJ; Pfeiler E; Thurmond TS; Turujman S; Walker NJ
Toxicol Sci; 2011 Oct; 123(2):333-48. PubMed ID: 21821733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
